Trial Profile
An Open Label Dose Titration Study of Quetiapine XR in the Treatment of Postpartum Depression in Nonlactating Women Diagnosed With Bipolar Disorder (BD), Type II.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar II disorders; Postnatal depression
- Focus Therapeutic Use
- 10 Feb 2012 New trial record